by Katie Hogan | Feb 25, 2026 | Market Access
Author: Alison Kneen, Global Market Access Practice Lead, BioVid Recent developments surrounding U.S. Most Favored Nation (MFN) pricing discussions and the Supreme Court’s ruling limiting tariff authority have largely been covered as isolated legal and political...
